Rationale for single and high dose treatment regimens with azithromycin

Pediatric Infectious Disease Journal

Volumn 23, Issue 2, 2004, Pages

  Gordon, Emma M ^a   Blumer, Jeffrey L ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Azithromycin; High dose; Pediatric; Pharmacodynamics; Pharmacokinetics; Respiratory tract infections; Single dose

Indexed keywords

AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CIPROFLOXACIN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; LEVOFLOXACIN; MACROLIDE; MOXIFLOXACIN; PENICILLIN DERIVATIVE; PENICILLIN G; PHORBOL 13 ACETATE 12 MYRISTATE; TELITHROMYCIN;

BACTERIAL PNEUMONIA; CONFERENCE PAPER; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG TISSUE LEVEL; DRUG UPTAKE; HAEMOPHILUS INFLUENZAE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NEUTROPHIL; NONHUMAN; OTITIS MEDIA; PHAGOCYTE; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; UPPER RESPIRATORY TRACT INFECTION;

EID: 1242269257     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000112523.95762.f5     Document Type: Conference Paper

References (27)

1. Reed MD, Blumer JL. Azithromycin: a critical review of the first azilide antibiotic and its role in pediatric practice. Pediatr Infect Dis J 1997;16:1069-83.
2. Block S, Arrieta A, Seibel M, McLinn S, Eppes S, Murphy MJ. Single-dose (30 mg/kg) azithromycin compared with amoxicillin/clavulanate for the treatment of uncomplicated acute otitis media. Curr Ther Res 2003;64(Suppl A):A30-42.
3. Dunne MW, Khurana C, Mohs AA, et al. Efficacy of single-dose azithromycin in treatment of acute otitis media in children after a baseline tympanocentesis. Antimicrob Agents Chemother 2003;47:2663-5.
4. Dunne MW, Latiolais T, Lewis B, et al. Randomized, double-blind study of the clinical efficacy of 3 days of azithromycin compared with co-amoxiclav for the treatment of acute otitis media. J Antimicrob Chemother 2003;52:469-72.
5. Rothermel C. Single-dose azithromycin for acute otitis media: a pharmacokinetic/pharmacodynamic rationale. Curr Ther Res 2003;64(Suppl A):A4-15.
6. Foulds G, Johnson RB. Selection of dose regimens of azithromycin. J Antimicrob Chemother 1993;31(Suppl E):39-50.
7. Arrieta A, Arguedas A, Fernandez P, et al. High-dose azithromycin versus high-dose amoxicillin-clavulanate for treatment of children with recurrent or persistent acute otitis media. Antimicrob Agents Chemother 2003;47:3179-86.
8. Abdel-Rahman SM, Kearns GL. The pharmacokinetic-pharmacodynamic interface: determinants of anti-infective drug action and efficacy in pediatrics. In: Feigin RD, Cherry JD, Demmler GJ, Kaplan SC, eds. Textbook of pediatric infectious diseases. 5th ed. Philadelphia: Saunders, 2004: 2965-87.
9. Hunstad DA, St. Jeme, JW III. Molecular determinants of microbial pathogenesis. In: Feigin RD, Cherry JD, Demmler GJ, Kaplan SC, eds. Textbook of pediatric infectious diseases. 5th ed. Philadelphia: Saunders, 2004:2-20.
10. Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 1998;26:1-10; quiz 11-12.
11. Ferguson J. The use of chemical potentials as indices of toxicity. Proc R Soc Lond Ser B 1939;127:387-404.
12. Eagle H, Fleischman R, Musselman A. The effective concentrations of penicillin in vitro and in vivo for streptococci, pneumococci, and Treponema pallidum. J Bacteriol 1950;59: 625-43.
13. Stevens RC, Reed MD, Shenep JL, et al. Pharmacokinetics of azithromycin after single- and multiple-doses in children. Pharmacotherapy 1997;17:874-80.
14. Girard AE, Cimochowski CR, Faiella JA. Correlation of increased azithromycin concentrations with phagocyte infiltration into sites of localized infection. J Antimicrob Chemother 1996;37(Suppl C):9-19.
15. Amsden GW, Gray CL. Serum and WBC pharmacokinetics of 1500 mg of azithromycin when given either as a single dose or over a 3 day period in healthy volunteers. J Antimicrob Chemother 2001;47:61-6.
16. Blandizzi C, Malizia T, Batoni G, et al. Distribution of azithromycin in plasma and tonsil tissue after repeated oral administration of 10 or 20 milligrams per kilogram in pediatric patients. Antimicrob Agents Chemother 2002;46: 1594-6.
17. Wildfeuer A, Laufen H, Zimmermann T. Uptake of azithromycin by various cells and its intracellular activity under in vivo conditions. Antimicrob Agents Chemother 1996;40:75-9.
18. Mandell GL, Coleman E. Uptake, transport, and delivery of antimicrobial agents by human polymorphonuclear neutrophils. Antimicrob Agents Chemother 2001;45:1794-8.
19. Hand WL, Hand DL. Characteristics and mechanisms of azithromycin accumulation and efflux in human polymorpho-nuclear leukocytes. Int J Antimicrob Agents 2001;18:419-25.
20. Gladue RP, Bright GM, Isaacson RE, Newborg MF. In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrob Agents Chemother 1989;33:277-82.
21. Hakansson A, Carlstedt I, Davies J, Mossberg AK, Sabharwal H, Svanborg C. Aspects on the interaction of Streptococcus pneumoniae and Haemophilus influenzae with human respiratory tract mucosa. Am J Respir Crit Care Med 1996; 154:S187-91.
22. Jecker P, McWilliam A, Napoli S, et al. Acute laryngitis in the rat induced by Moraxella catarrhalis and Bordetella pertussis: number of neutrophils, dendritic cells, and T and B lymphocytes accumulating during infection in the laryngeal mucosa strongly differs in adjacent locations. Pediatr Res 1999;46:760-6.
23. Ichimiya I, Suzuki M, Hirano T, Mogi G. The influence of pneumococcal otitis media on the cochlear lateral wall. Hear Res 1999;131:128-34.
24. Tong HH, Blue LE, James MA, Chen YP, DeMaria TF. Evaluation of phase variation of nontypeable Haemophilus influenzae lipooligosaccharide during nasopharyngeal colonization and development of otitis media in the chinchilla model. Infect Immun 2000;68:4593-7.
25. Melhus A, Ryan AF. Expression of cytokine genes during pneumococcal and nontypeable Haemophilus influenzae acute otitis media in the rat. Infect Immun 2000;68:4024-31.
26. Rynnel-Dagoo B, Agren, K. The nasopharynx and the middle ear: inflammatory reactions in middle ear disease. Vaccine 2001;19:S26-31.
27. Girard D, Finegan SM, Cimochowski CR, Dunne MW, Giovanis A. Accelerated dosing of azithromycin in preclinical infection models. Poster presented at the 102nd American Society for Microbiology General Meeting, Salt Lake City, UT, May 19 to 23, 2002.